Chimerix, Inc.

Market Cap: Micro Cap
Industry: Pharmaceuticals: Major
ISIN: US16934W1062

USD

8.54

-0.01 (-0.12%)

Apr 22

NAS

Click here to see other stocks

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

MediWound Ltd.

Pyxis Oncology, Inc.

Aquestive Therapeutics, Inc.

Chimerix, Inc.

DiaMedica Therapeutics, Inc.

GlycoMimetics, Inc.

Milestone Pharmaceuticals, Inc.

Achieve Life Sciences, Inc.

Atossa Therapeutics, Inc.

MediciNova, Inc.

Relmada Therapeutics, Inc.

Why is Chimerix, Inc. ?

Unrated Stock - No Analysis Available

Real-Time Research Report

Verdict Report

No Data Found

Is Chimerix, Inc. for you?

High Risk, High Return

Absolute

Risk Adjusted

Volatility

Chimerix, Inc.

844.69%

3.31

254.98%

S&P 500

13.22%

0.61

20.23%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

-55.85%

EBIT Growth (5y)

-167.01%

EBIT to Interest (avg)

-77.01

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-1.08

Sales to Capital Employed (avg)

0.06

Tax Ratio

Dividend Payout Ratio

Pledged Shares

Institutional Holding

72.15%

ROCE (avg)

ROE (avg)

13.41%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

6.31

EV to EBIT

-6.60

EV to EBITDA

-6.60

EV to Capital Employed

-68.92

EV to Sales

637.13

PEG Ratio

Dividend Yield

98.61%

ROCE (Latest)

Negative Capital Employed

ROE (Latest)

-72.64%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bullish

RSI

Bearish

Bollinger Bands

Mildly Bullish

Bullish

Moving Averages

Bullish (Daily)

KST

Bullish

Dow Theory

Bearish

No Trend

OBV

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

Not enough Data to analyse Financial Trend

Here's what is working for Chimerix, Inc.

Net Sales

At USD 0.08 MM has Grown at 453.33%

Year on Year (YoY)

MOJO Watch

Sales trend is very positive

Net Sales (USD MM)

Debt-Equity Ratio

Lowest at -107.22 % and Grown

In each half year in the last five Semi-Annual periods

MOJO Watch

The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Here's what is not working for Chimerix, Inc.

Operating Cash Flow

Lowest at USD -75.38 MM and Fallen

In each year in the last three years

MOJO Watch

The company's cash revenues from business operations are falling

Operating Cash Flows (USD MM)

Pre-Tax Profit

Lowest at USD -22.95 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is negative

Pre-Tax Profit (USD MM)

Pre-Tax Profit

Fallen at -26.39%

Year on Year (YoY)

MOJO Watch

Near term Pre-Tax Profit trend is negative

Pre-Tax Profit (USD MM)

Net Profit

Lowest at USD -22.95 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is negative

Net Profit (USD MM)

Net Profit

Fallen at -26.39%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is negative

Net Profit (USD MM)

Debtors Turnover Ratio

Lowest at 0.22%

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling Debtors has slowed

Debtors Turnover Ratio

Raw Material Cost

Grown by 47.85% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales